Comparative diabetes mellitus burden trends across global, Chinese, US, and Indian populations using GBD 2021 database

Сравнительные тенденции бремени сахарного диабета среди населения мира, Китая, США и Индии на основе базы данных GBD 2021
Zhiyong Hou, Min Jiang, Xinxin Liu, Yafei Chen, Guoyu Wang, Siyi Ma
2025-04-08

Bayesian age-period-cohort modelDisability-adjusted life yearsGlobal Burden of Disease (GBD) 2021Type 1 diabetes mellitusType 2 diabetes mellitus
Diabetic mellitus (DM) poses a significant challenge and stress to global health, comparing the burden of disease in the world's three most populous countries while projecting changes in trends in age-standardized rate (ASR) -deaths and disability adjusted life years (DALYs) up to 2050. Using GBD2021 data, we examined DM trends in China, US, India and globally for 1990-2021, and projected deaths and DALYs for DM (types 1 and 2) for 2022-2050 using Bayesian age-period-cohort (BAPC) model. It was found that the ASR-DALYs and deaths for T1DM are trending downward globally, while those for T2DM are trending upward. In terms of gender differences, the burden of T1DM by gender was insignificant, whereas the burden of disease was significantly higher in men with T2DM than in women. The burden of disease for T1DM peaks around the ages of 40-44 years, while the burden of disease for T2DM peaks at 65-69 years. Population growth and ageing are major factors influencing the disease burden of diabetes. The projection of ASR-deaths and DALYs globally for 2022-2050 showed a decreasing trend in T1DM and an increasing trend in T2DM (especially in China and India). The increasing burden of T2DM disease globally and in three countries by 2050 should be taken seriously.
1
Age-standardized mortality and DALY rates for type 1 diabetes decreased globally, whereas corresponding type 2 diabetes rates increased.
2
Population growth and ageing substantially influenced diabetes burden; projections indicate declining type 1 diabetes but increasing type 2 diabetes through 2050, especially in China and India.
3
Type 1 diabetes burden peaked at ages 40–44 years, whereas type 2 diabetes burden peaked at ages 65–69 years.
4
Type 1 diabetes burden showed no substantial gender difference, while type 2 diabetes burden was significantly higher among men than women.
5
Using GBD 2021 data, the study compared diabetes mortality and DALY trends globally and in China, the United States, and India from 1990–2021, projecting outcomes through 2050.

Diabetes mellitus (type 1 and type 2) in global, Chinese, US, and Indian populations

Comparative temporal and projected trends in diabetes burden, including age-standardized deaths and DALYs, differences by sex and age, and the influence of population growth and ageing from 1990 to 2050

Publication Details
Publication Date
2025-04-08
Journal
Publisher
ISSN
Cited by
32
Access Type
Author Information
Authors
Zhiyong Hou
Min Jiang
Xinxin Liu
Yafei Chen
Guoyu Wang
Siyi Ma
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%